Literature DB >> 28960897

A uniform-shear rate microfluidic bioreactor for real-time study of proplatelet formation and rapidly-released platelets.

Andres F Martinez1, Richard D McMahon2, Marc Horner3, William M Miller4.   

Abstract

Platelet transfusions, with profound clinical importance in blood clotting and wound healing, are entirely derived from human volunteer donors. Hospitals rely on a steady supply of donations, but these methods are limited by a 5-day shelf life, the potential risk of contamination, and differences in donor/recipient histocompatibility. These challenges invite the opportunity to generate platelets ex vivo. Although much progress has been made in generating large numbers of culture-derived megakaryocytes (Mks, the precursor cells to platelets), stimulating a high percentage of Mks to undergo platelet release remains a major challenge. Recent studies have demonstrated the utility of shear forces to enhance platelet release from cultured Mks. In this study, we performed a computational fluid dynamics (CFD) analysis of several published platelet microbioreactor systems, and used the results to develop a new 7-µm slit bioreactor-with well-defined flow patterns and uniform shear profiles. This uniform-shear-rate bioreactor (USRB-7µm) permits real-time visualization of the proplatelet (proPLT) formation process and the rapid-release of individual platelet-like-particles (PLPs), which has been observed in vivo, but not previously reported for platelet bioreactors. We showed that modulating shear forces and flow patterns had an immediate and significant impact on PLP generation. Surprisingly, using a single flow instead of dual flows led to an unexpected six-fold increase in PLP production. By identifying particularly effective operating conditions within a physiologically relevant environment, this USRB-7µm will be a useful tool for the study and analysis of proPLT/PLP formation that will further understanding of how to increase ex vivo platelet release.
© 2017 American Institute of Chemical Engineers Biotechnol. Prog., 33:1614-1629, 2017. © 2017 American Institute of Chemical Engineers.

Entities:  

Keywords:  CFD; cell therapies; megakaryocytes; microfluidic bioreactor; platelets

Mesh:

Year:  2017        PMID: 28960897      PMCID: PMC5745287          DOI: 10.1002/btpr.2563

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  29 in total

Review 1.  Adhesion and homing of blood-borne cells in bone marrow microvessels.

Authors:  I B Mazo; U H von Andrian
Journal:  J Leukoc Biol       Date:  1999-07       Impact factor: 4.962

2.  A novel bioreactor and culture method drives high yields of platelets from stem cells.

Authors:  Mauro P Avanzi; Oluwasijibomi E Oluwadara; Melissa M Cushing; Maxwell L Mitchell; Stephen Fischer; W Beau Mitchell
Journal:  Transfusion       Date:  2015-10-15       Impact factor: 3.157

Review 3.  Overview on platelet preservation: better controls over storage lesion.

Authors:  Hitoshi Ohto; Kenneth E Nollet
Journal:  Transfus Apher Sci       Date:  2011-04-19       Impact factor: 1.764

4.  Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies.

Authors:  Christian A Di Buduo; Lindsay S Wray; Lorenzo Tozzi; Alessandro Malara; Ying Chen; Chiara E Ghezzi; Daniel Smoot; Carla Sfara; Antonella Antonelli; Elise Spedden; Giovanna Bruni; Cristian Staii; Luigi De Marco; Mauro Magnani; David L Kaplan; Alessandra Balduini
Journal:  Blood       Date:  2015-01-09       Impact factor: 22.113

Review 5.  Platelet bioreactor: accelerated evolution of design and manufacture.

Authors:  Jonathan N Thon; Brad J Dykstra; Lea M Beaulieu
Journal:  Platelets       Date:  2017-01-23       Impact factor: 3.862

6.  Three-dimensional system for the in vitro study of megakaryocytes and functional platelet production using silk-based vascular tubes.

Authors:  Isabella Pallotta; Michael Lovett; David L Kaplan; Alessandra Balduini
Journal:  Tissue Eng Part C Methods       Date:  2011-09-06       Impact factor: 3.056

Review 7.  Challenges and promises for the development of donor-independent platelet transfusions.

Authors:  Michele P Lambert; Spencer K Sullivan; Rudy Fuentes; Deborah L French; Mortimer Poncz
Journal:  Blood       Date:  2013-01-15       Impact factor: 22.113

8.  Circulating megakaryocytes: delivery of large numbers of intact, mature megakaryocytes to the lungs.

Authors:  R F Levine; A Eldor; P K Shoff; S Kirwin; D Tenza; E M Cramer
Journal:  Eur J Haematol       Date:  1993-10       Impact factor: 2.997

9.  IL-1α induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs.

Authors:  Satoshi Nishimura; Mika Nagasaki; Shinji Kunishima; Akira Sawaguchi; Asuka Sakata; Hiroyasu Sakaguchi; Tsukasa Ohmori; Ichiro Manabe; Joseph E Italiano; Tomiko Ryu; Naoya Takayama; Issei Komuro; Takashi Kadowaki; Koji Eto; Ryozo Nagai
Journal:  J Cell Biol       Date:  2015-05-11       Impact factor: 10.539

10.  Microfluidic model of the platelet-generating organ: beyond bone marrow biomimetics.

Authors:  Antoine Blin; Anne Le Goff; Aurélie Magniez; Sonia Poirault-Chassac; Bruno Teste; Géraldine Sicot; Kim Anh Nguyen; Feriel S Hamdi; Mathilde Reyssat; Dominique Baruch
Journal:  Sci Rep       Date:  2016-02-22       Impact factor: 4.379

View more
  3 in total

1.  Enabling Large-Scale Ex Vivo Production of Megakaryocytes from CD34+ Cells Using Gas-Permeable Surfaces.

Authors:  Andres F Martinez; William M Miller
Journal:  Stem Cells Transl Med       Date:  2019-03-08       Impact factor: 6.940

Review 2.  Generation and manipulation of human iPSC-derived platelets.

Authors:  Naoshi Sugimoto; Koji Eto
Journal:  Cell Mol Life Sci       Date:  2021-01-13       Impact factor: 9.261

Review 3.  On the Quest for In Vitro Platelet Production by Re-Tailoring the Concepts of Megakaryocyte Differentiation.

Authors:  Patricia Martínez-Botía; Andrea Acebes-Huerta; Jerard Seghatchian; Laura Gutiérrez
Journal:  Medicina (Kaunas)       Date:  2020-12-03       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.